Titre du document / Document title

Effect of an aldose reductase inhibitor on esophageal dysfunction in diabetic patients

Auteur(s) / Author(s)

KINEKAWA Fumihiko ^{(1 2)} ; KUBO Fumiyoshi ⁽²⁾ ; MATSUDA Kazuya ⁽¹⁾ ; FUJITA Yoko ⁽²⁾ ; KOBAYASHI Mitsuyoshi ^{(1 2)} ; FUNAKOSHI Fumi ⁽¹⁾ ; UCHIDA Naohito ⁽¹⁾ ; WATANABE Seishiro ⁽¹⁾ ; TOMITA Tadataka ⁽²⁾ ; UCHIDA Yoshihito ⁽³⁾ ; KURIYAMA Shigeki ⁽¹⁾ ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

⁽¹⁾ Third Department of Internal Medicine, Kagawa University School of Medicine, JAPON
⁽²⁾ Department of Internal Medicine, Uchinomi Hospital, JAPON
⁽³⁾ Department of Internal Medicine Takuma Municipal National Health Insurance Eikou Hospital, Kagawa, JAPON

Résumé / Abstract

Background/Aims: Disorders of the digestive tract in diabetic patients are mainly ascribed to disorders of the vagus nerve. Although aldose reductase inhibitors (ARIs) have been shown to be effective against diabetic peripheral neuropathy, their effectiveness on diabetic digestive neuropathy remains to be evaluated. The aim of the present study is to examine the effect of an ARI on the esophageal dysfunction in diabetic patients by monitoring pH and motility of the esophagus. Methodology: Eight type 2 diabetic patients with peripheral neuropathy were administered with the ARI epalrestat (150mg/day) for 90 days, and esophageal pH and motility were monitored before and after the ARI treatment. Results: Parameters related to the gastroesophageal acid reflux and the esophageal motility, such as % time of pH<4, DeMeester score, duration of the longest reflux episode, reflux episodes longer than 5 min, ratios of peristaltic waves with the amplitude greater than 25 mmHg and ratios of effective peristalsis were remarkably improved by the ARI treatment. Conclusions: Because the present study clearly demonstrated the effectiveness of an ARI on the esophageal dysfunction in diabetic patients, ARI may be useful for the treatment of diabetic digestive disorders.

Revue / Journal Title

Hepato-gastroenterology   ISSN 0172-6390   CODEN HEGAD4 

Source / Source

2005, vol. 52, n^o62, pp. 471-474 [4 page(s) (article)] (21 ref.)

Langue / Language

Anglais

Editeur / Publisher

Thieme, Stuttgart, ALLEMAGNE  (1980) (Revue)

Mots-clés anglais / English Keywords

Aldehyde reductase ; Endocrinopathy ; Enzyme inhibitor ; Enzyme ; Oxidoreductases ; Motility ; Acids ; Human ; Dysfunction ; Esophagus ; Reductase ; Epalrestat ; Diabetes mellitus ;

Mots-clés français / French Keywords

Aldehyde reductase ; Endocrinopathie ; Inhibiteur enzyme ; Enzyme ; Oxidoreductases ; Motilité ; Acide ; Homme ; Trouble fonctionnel ; Oesophage ; Reductase ; Epalrestat ; Diabète ;

Mots-clés espagnols / Spanish Keywords

Aldehyde reductase ; Endocrinopatía ; Inhibidor enzima ; Enzima ; Oxidoreductases ; Motilidad ; Acido ; Hombre ; Trastorno funcional ; Esófago ; Reductase ; Epalrestat ; Diabetes ;

Mots-clés d'auteur / Author Keywords

Aldose reductase inhibitor ; Esophageal dysfunction ; Diabetes mellitus ; Epalrestat ; Esophageal acid reflux ; Esophageal motility ;

Localisation / Location

INIST-CNRS, Cote INIST : 9633, 35400012536976.0330